Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
28.32
-0.05 (-0.18%)
At close: Jun 18, 2026, 4:00 PM EDT
28.30
-0.02 (-0.07%)
After-hours: Jun 18, 2026, 4:10 PM EDT
LKFT Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 66.81 | 87.87 | 64.24 | 166.8 | 508.12 | 2,233 |
Short-Term Investments | 2,915 | 2,910 | 3,053 | 3,518 | 3,586 | 2,470 |
Cash & Short-Term Investments | 2,982 | 2,998 | 3,118 | 3,685 | 4,094 | 4,703 |
Cash Growth | -9.55% | -3.83% | -15.39% | -10.00% | -12.95% | -8.88% |
Accounts Receivable | 21.74 | 20.71 | 47.48 | 28.45 | 40.43 | 111.34 |
Other Receivables | 32.3 | 31.21 | 39.88 | 37.44 | 26.13 | 16.83 |
Total Trade Receivables | 54.03 | 51.91 | 87.36 | 65.89 | 66.56 | 128.16 |
Inventory | 17.69 | 22.49 | 51.19 | 73.98 | 52.93 | 20.57 |
Other Current Assets | 6.77 | 7 | 83.33 | 37.23 | 23.31 | 9.95 |
Total Current Assets | 3,061 | 3,079 | 3,339 | 3,862 | 4,237 | 4,862 |
Net Property, Plant & Equipment | 76.95 | 80.66 | 122.9 | 126.32 | 154.25 | 137.51 |
Other Intangible Assets | 0.75 | 0.85 | 164.86 | 127.91 | 146.35 | 60.1 |
Goodwill | - | - | 70.01 | 69.56 | 69.81 | - |
Long-Term Investments | 116.3 | 115.73 | 295.59 | 13.58 | - | - |
Other Long-Term Assets | 117.69 | 129.82 | 142.91 | 158.45 | 127.08 | 133.69 |
Total Assets | 3,372 | 3,407 | 4,136 | 4,357 | 4,734 | 5,193 |
Accounts Payable | 95.77 | 104.65 | 98.88 | 135.2 | 148.68 | 137.62 |
Current Portion of Leases | 1.58 | 1.73 | 3.48 | 4.65 | 7.21 | 7.2 |
Unearned Revenue | 0.03 | 0.03 | 232.48 | 256.27 | 365.63 | 419.87 |
Other Current Liabilities | 3.04 | 46.46 | 0.25 | 32.1 | 1.02 | 1.78 |
Total Current Liabilities | 100.42 | 152.86 | 335.08 | 428.22 | 522.54 | 566.47 |
Long-Term Leases | 4.85 | 5.19 | 8.24 | 4.94 | 14.69 | 19.66 |
Other Long-Term Liabilities | 13.79 | 12.6 | 895.46 | 1,129 | 1,671 | 1,964 |
Total Long-Term Liabilities | 18.64 | 17.79 | 903.7 | 1,134 | 1,686 | 1,983 |
Total Liabilities | 119.06 | 170.65 | 1,239 | 1,562 | 2,208 | 2,550 |
Common Stock | 293.94 | 293.94 | 293.94 | 293.94 | 293.6 | 292.08 |
Additional Paid-in Capital | 2,737 | 2,737 | 2,737 | 2,737 | 2,736 | 2,730 |
Accumulated Other Comprehensive Income | 2.74 | 3 | 3.47 | -1.2 | -1.59 | -1.72 |
Retained Earnings | 219.7 | 201.94 | -137.46 | -234.16 | -501.54 | -377.38 |
Shareholders' Equity | 3,253 | 3,236 | 2,897 | 2,796 | 2,526 | 2,643 |
Total Liabilities & Equity | 3,372 | 3,407 | 4,136 | 4,357 | 4,734 | 5,193 |
Total Debt | 6.44 | 6.92 | 11.72 | 9.6 | 21.9 | 26.86 |
Net Cash (Debt) | 2,976 | 2,991 | 3,106 | 3,675 | 4,072 | 4,676 |
Net Cash Growth | -0.51% | -3.69% | -15.48% | -9.75% | -12.92% | -8.88% |
Net Cash Per Share | 45.17 | 45.39 | 47.13 | 55.78 | 61.98 | 71.39 |
Book Value | 3,253 | 3,236 | 2,897 | 2,796 | 2,526 | 2,643 |
Book Value Per Share | 49.39 | 49.10 | 43.96 | 42.43 | 38.45 | 40.36 |
Tangible Book Value | 3,253 | 3,235 | 2,662 | 2,598 | 2,310 | 2,583 |
Tangible Book Value Per Share | 49.38 | 49.09 | 40.40 | 39.43 | 35.16 | 39.44 |